Benefits of Low-Intensity Pain-Free Treadmill Exercise on Functional Capacity of Individuals Presenting with Intermittent Claudication Due to Peripheral Arterial Disease
Restricted accessResearch articleFirst published online August, 2009
Benefits of Low-Intensity Pain-Free Treadmill Exercise on Functional Capacity of Individuals Presenting with Intermittent Claudication Due to Peripheral Arterial Disease
Patients with intermittent claudication due to peripheral arterial disease (PAD) experience muscle aching during walking secondary to ischemia. The purpose of this study was to examine the effects of low-intensity pain-free exercise (LIPFE) on functional capacity of individuals with PAD. A total of 12 participants with PAD underwent training on treadmill for 6 weeks, twice a week, for about 45 minutes. Outcome measures included walking distance (WDI), walking duration (WDU), mean walking rate (WR), estimated oxygen consumption (EVO2), metabolic equivalent (MET), estimated total energy expenditure (ETEE), and estimated rate of energy expenditure (EREE). Mean improvement of WDI, WDU, and MWR were 104% (an addition of 1.0 km), 55% (an addition of 13.3 minutes), and 41% (0.9 km/h faster), respectively. Mean improvement of EVO2, MET, ETEE, and EREE, were 20%, 20%, 80%, and 20%, respectively. In conclusion, it appears that LIPFE training is an effective intervention for individuals presenting with PAD.
HirschA.T., CriquiM.H., Treat-JacobsonD.Peripheral arterial disease detection, awareness, and treatment in primary care.JAMA.2001; 286: 1317–1324.
3.
HiattW.R., WolfelE.E., MeierR.H., RegensteinerJ.G.Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response.Circulation.1994; 90: 1866–1874.
4.
HertzerN.R.The natural history of peripheral vascular disease. Implications for its management.Circulation1991; 83: 112–119.
5.
RadackK., WyderskiR.J.Conservative management of intermittent claudication.Ann Intern Med.1990; 113: 135–146.
6.
PattersonR.B., PintoB., MarcusB., ColucciA., BraunT., RobertsM.Value of a supervised exercise program for the therapy of arterial claudication.J Vasc Surg1997; 25: 312–318.
7.
GardnerA.W., PoehlmanE.T.Exercise rehabilitation programs for the treatment of claudication pain. A metaanalysis.JAMA.1995; 274: 975–980.
8.
HiattW.R., RegensteinerJ.G., HargartenM.E., WolfelE.E., BrassE.P.Benefit of exercise conditioning for patients with peripheral arterial disease.Circulation.1990; 81: 602–609.
9.
LundgrenF., DahllöfA.G., SchersténT., Bylund-FelleniusA.C.Muscle enzyme adaptation in patients with peripheral arterial insufficiency: spontaneous adaptation, effect of different treatments and consequences on walking performance.Clin Sci (Lond).1989; 77: 485–493.
10.
MannarinoE., PasqualiniL., MennaM., MaragoniG., OrlandiU.Effects of physical training on peripheral vascular disease: a controlled study.Angiology.1989; 40: 5–10.
11.
FernandezB.B.Jr.A rational approach to diagnosis and treatment of intermittent claudication.Am J Med Sci.2002; 323: 244–251.
12.
American College of Sports Medicine (ACSM). ACSM guidelines for exercise testing and prescription.Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
13.
TsaiJ.C., ChanP., WangC.H.The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease.J Intern Med.2002; 252: 448–455.
14.
Izquierdo-PorreraA.M., GardnerA.W., PowellC.C., KatzelL.I.Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.J Vasc Surg.2000; 31: 670–677.
15.
BoydC.E., BirdP.J., TeatesC.D., WellonsH.A., MacDougallM.A., WolfeL.A.Pain free physical training in intermittent claudication.J Sports Med Phys Fitness.1984; 24: 112–122.
16.
MondilloS., BalloP., BarbatiR.Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease.Am J Med.2003; 114: 359–364.
17.
AronowW.S., NayakD., WoodworthS., AhnC.Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment.Am J Cardiol.2003; 92: 711–712.
18.
GiriJ., McDermottM.M., GreenlandP.Statin use and functional decline in patients with and without peripheral arterial disease.J Am Coll Cardiol.2006; 47: 998–1004.
19.
BrooksG.A., FaheyT.D., WhiteT.G.Exercise Physiology: Human Bioenergetics and Its Applications.Mountain View, CA: Mayfield; 2000.
20.
JacksonA.S., BeardE.F., WierL.T., RossR.M., StutevilleJ.E., BlairS.N.Changes in aerobic power of men, ages 25–70 yr.Med Sci Sports Exerc.1995; 27: 113–120.
21.
JacksonA.S., WierL.T., AyersG.W., BeardE.F., StutevilleJ.E., BlairS.N.Changes in aerobic power of women, ages 20–64 yr.Med Sci Sports Exerc.1996; 28: 884–891.
22.
GardnerA.W.Claudication pain and hemodynamic responses to exercise in younger and older peripheral arterial disease patients.J Gerontol.1993; 48: M231–M236.
23.
TanK.H., De CossartL., EdwardsP.R.Exercise training and peripheral vascular disease.Br J Surg.2000; 87: 553–562.
24.
HiattW.R., RegensteinerJ.G., WolfelE.E., CarryM.R., BrassE.P.Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease.J Appl Physiol.1996; 81: 780–788.
